Allergan Says Drug Buyers Trying To Delay Case 'Indefinitely'
Allergan slammed buyers of its ulcerative colitis drug for indefinitely trying to stay their antitrust suit while a judge reconsiders their bid for class certification, telling a Massachusetts federal court Thursday...To view the full article, register now.
Already a subscriber? Click here to view full article